Considering that hyper-activation of PI3K-Akt-mTOR cascade is vital for tumorigenesis, progression and therapy-resistance of NSCLC [6, 26–28], we therefore analyzed the potential role of SLC5A3 on Akt-mTOR activation in NSCLC cells. This evidence concerns the gene MTOR and non-small cell lung carcinoma.